Pfizer says Israel data shows the third Covid shot restores protection
![The third Covid shot restores protection, according to Pfizer](https://globalhealthcareoutlook.com/wp-content/uploads/2022/06/Picture1-35-1024x576.png)
September 17, 2021: -According to data submitted to the Food and Drug Administration, a third dose of Pfizer’s Covid vaccine six months after a second dose gives 95% protection from infection in a world set in Israel.
Pfizer plans to file for full FDA approval of the Covid vaccine
![Pfizer plans to file for full FDA approval of the Covid vaccine](https://globalhealthcareoutlook.com/wp-content/uploads/2022/06/Picture1-34-1024x576.png)
May 5, 2021: -On Tuesday, Pfizer said it plans to file for full U.S. approval of its Covid-19 vaccine with German drugmaker BioNTech at this month-end. The company will be able to market the shot directly to consumers if the company signs off.
Pfizer CEO warns of the early need for fourth Covid dose
![Pfizer CEO warns of the early need for fourth Covid dose](https://globalhealthcareoutlook.com/wp-content/uploads/2022/06/Picture1-33-1024x576.png)
December 10, 2021: -Pfizer CEO Albert Bourla said Wednesday that people might need a fourth Covid-19 shot sooner than expected after preliminary research shows the new omicron variant can undermine protective antibodies generated by the vaccine the company developed with BioNTech.
Pfizer and BioNTech Covid vaccine scientist recommend the third shot
![Pfizer and BioNTech Covid vaccine scientist recommend the third shot](https://globalhealthcareoutlook.com/wp-content/uploads/2022/06/Picture1-32-1024x576.png)
April 23, 2021: -On Wednesday, the chief medical officer of BioNTech told CNBC that people would likely need a third dose of its two-dose Covid-19 vaccine as immunity against the virus wanes, agreeing with previous comments made by Pfizer CEO Albert Bourla.
Omicron will challenge Hong Kong’s zero-Covid policy
![Omicron will challenge Hong Kong’s zero-Covid policy](https://globalhealthcareoutlook.com/wp-content/uploads/2022/06/Picture1-31-1024x576.png)
January 17, 2022: -The highly transmissible omicron variant will be a “tough challenge” for Hong Kong as the city sticks to its zero-Covid policy, a former U.S. diplomat told CNBC.
Officials defend AstraZeneca vaccine after U.K., E.U. blood clot guidance
![Officials defend AstraZeneca vaccine after blood clot bans](https://globalhealthcareoutlook.com/wp-content/uploads/2022/06/Picture1-30-1024x576.png)
April 9, 2021:-The British government and health experts in the country are rushing to defend the COVID-19 vaccine by AstraZeneca, and the University of Oxford follows concerns over a link to blood clot.
‘Nobody will wear’ coronavirus masks by June
![‘Nobody will wear’ coronavirus masks by June](https://globalhealthcareoutlook.com/wp-content/uploads/2022/06/Picture1-29-1024x576.png)
May 18, 2021: -On Monday, Dr. Scott Gottlieb said he expects more Americans to stop wearing face masks to protect against the coronavirus in the coming weeks.
New Zealand is dropping its Covid-19 elimination plan
![New Zealand is dropping its Covid-19 elimination plan](https://globalhealthcareoutlook.com/wp-content/uploads/2022/06/Picture1-28-1024x576.png)
October 5, 2021: On Monday, New Zealand abandoned its elimination of coronavirus, easing some Covid-19 lockdown restrictions in its biggest city Auckland. It will instead look to live with the virus while controlling its spread.
Moderna says its Covid vaccine is 100% effective
![Moderna says its Covid vaccine is 100% effective](https://globalhealthcareoutlook.com/wp-content/uploads/2022/06/Picture1-27-1024x576.png)
May 26, 2021: -On Tuesday, Moderna said its Covid-19 vaccine was 100% effective in a study of adolescents ages 12 to 17, making it the second shot behind Pfizer’s to demonstrate high efficacy in younger age groups.
Moderna says its Covid booster produced a ‘robust’ immune response
![Moderna says its Covid booster produced a ‘robust’ immune response](https://globalhealthcareoutlook.com/wp-content/uploads/2022/06/Picture1-54-1024x576.png)
August 6, 2021: On Thursday, according to details of a study released with the company’s second-quarter earnings report, Moderna said its Covid-19 vaccine booster dose produced a “robust” antibody response against the highly contagious delta variant.